UK Government Delaying NHS Access to New Cancer Drugs to Save Money, Say Experts

Cancer experts have accused the British government of ‘systematically’ delaying the introduction of new cancer drugs on the NHS (National Health Service) in order to save money.

The British government has been accused of ‘systematically’ delaying the introduction of new cancer drugs on the NHS (National Health Service) in order to save money.

The NHS is a health care service offering care to all residents of the United Kingdom. The European Health Insurance Card (EHIC) issued by the NHS gets members state-provided healthcare in all European Economic Area (EEA) countries and Switzerland.

6 Million American Children Have No Health Insurance
Many US insurers stopped offering individual coverage for children after the 2010 health care overhaul as no child could be refused on the grounds of pre-existing diseases.

The accusation comes from no less than a leading cancer specialist and the head of Britain’s biggest drugs company.

Professor Jonathan Waxman, a cancer specialist with the Imperial College London, said that innovative drugs were being held back as part of an ill-conceived attempt to cut costs.

Describing the situation as a disaster, he said a number of new cancer drugs had been blocked for use on the NHS by the National Institute for Health and Clinical Excellence (NICE).

Karnataka Bank Ltd Rolls Out New Health Insurance Product
The Karnataka Bank Ltd. has tied up with Universal Sompo General Insurance Co Ltd, to provide a health insurance scheme called ‘K Family Care’.

Sir Andrew Witty chief executive at GlaxoSmithKline, told the BBC, ‘We're seeing oncology drugs being systematically delayed from introduction and reimbursement.’ He said that more expensive medicines were being delayed in a whole series of different diseases across Europe.

'Ultimately it's one of those situations where the drift will be imperceptibly happening, but when you look back in five or 10 years, a huge gap will have opened up,' he said.

Californian Health Insurance Companies to Hike Premiums by 8% to 14%
California’s largest health insurance companies will be increasing their average rates by 8% to 14% for hundreds of thousands of policyholders having individual coverage.

The Department of Health has rejected these claims and said the approval process was speeding up, and that it had increased spending on new drugs.

Health Insurance, AI, Railways to Get Resources Due to Hike in GDS
Resource-starved sectors like the Railways, Air India & the UPA’s flagship programmes will get resources due to the 18% hike of Rs. 521,000 crores in the Gross Budgetary Support for planned expenses.

Source-Medindia